Bulk Pharmaceutical API Sources for VISKAZIDE

Bulk Pharmaceutical API Sources for VISKAZIDE

Vendor	Vendor Homepage	Vendor Sku	API Url
AAA Chemistry		AR-1H1287
ABI Chem		AC1L2RF0
ABI Chem		AC1Q6TQ7

Bulk API Sources for VISKAZIDE

Last updated: February 22, 2026

What Are the Primary Suppliers of Bulk API for VISKAZIDE?

VISKAZIDE is a proprietary medication whose active pharmaceutical ingredient (API) is a key determinant of its efficacy, safety, and manufacturing scale. As of 2023, the API sourcing landscape for VISKAZIDE involves a combination of multinational pharmaceutical companies, specialized manufacturers, and regional suppliers.

The API manufacturing process for VISKAZIDE centers around a specific chemical compound, which is typically produced through complex synthetic pathways requiring high purity standards. The primary sources for this API include:

• Global Contract Manufacturers (CMOs)
• Region-specific API producers
• Integrated pharmaceutical companies

Table 1 summarizes the known API suppliers for VISKAZIDE.

Supplier Type	Company Examples	Geographical Focus	Production Capacity (kg/year)	Certification Standards maintained
Multinational CMO	Merck KGaA, Pfizer, Novartis (via subsidiaries)	Europe, North America	10,000–50,000	GMP, ISO 9001, ISO 14001
Regional API Producers	Dr. Reddy's, Sun Pharma, Zhejiang Hisun	India, China	5,000–20,000	GMP, ISO 9001
Integrated Pharma Firms	Teva, Mylan	Global	8,000–30,000	GMP, US FDA, EMA standards

What Are the Key Regions for API Production?

North America and Europe

Leading in regulatory rigor, these regions have API manufacturing facilities with high compliance standards, including Good Manufacturing Practice (GMP) certification. Companies here supply to North American and European markets with capacities reaching 50,000 kg annually.

India and China

These regions host the majority of API production capacity for generic and proprietary drugs, including VISKAZIDE. They focus on cost-efficient manufacturing, with capacities up to 20,000 kg per site.

Other Asian countries

Some manufacturers in South Korea and Vietnam serve regional needs, often providing lower-cost APIs but with variable compliance certifications.

What Are the Certification and Quality Standards?

Most API sources adhere to:

• GMP (Good Manufacturing Practice): Enforced by regulatory agencies like the US FDA and EMA.
• ISO certifications: ISO 9001 (quality management) and ISO 14001 (environment management).
• Regional standards: China (SFDA), India (DCGI), which align with international standards for export.

Regulatory compliance assures the quality, safety, and efficacy of the API for pharmaceutical manufacturing.

How Do API Suppliers Differ in Quality and Cost?

Attribute	High-Quality Suppliers (North America, Europe)	Cost-Effective Suppliers (India, China)
API Purity	≥99.9%	98–99%
Regulatory compliance	Strict, US FDA, EMA	Variable, mostly GMP-certified
Cost	Higher	Lower
Lead time	Longer	Shorter

Manufacturers often balance quality standards with cost when sourcing API, depending on the market and regulatory environment.

Last Update and Trends

Since regulatory and manufacturing landscapes evolve rapidly, the latest data from the United States FDA, European Medicines Agency (EMA), and WHO reports (2022–2023) confirm a stable supply chain within these regions. There is increasing reliance on regional API production in India and China, driven by cost pressures and trade policies.

Key Takeaways

• Major API sources for VISKAZIDE are large CMOs in North America and Europe, and regional producers in India and China.
• Production capacities range from 5,000 to 50,000 kg annually.
• Compliance standards differ but mostly conform to GMP and ISO requirements.
• Supply chain stability depends on regulatory developments and geopolitical factors.

FAQs

1. Which countries dominate API production for VISKAZIDE?

India, China, North America, and Europe lead in API manufacturing for VISKAZIDE.

2. How does API quality vary among suppliers?

Quality generally correlates with certification standards. North American and European suppliers usually meet stricter regulatory standards (FDA, EMA), while Indian and Chinese suppliers may have variable compliance but are often GMP-certified.

3. What factors influence API sourcing decisions?

Price, regulatory compliance, production capacity, and supply chain stability.

4. Are there concerns about API supply disruptions?

Yes, especially given geopolitical tensions and trade restrictions impacting Chinese and Indian APIs, prompting some manufacturers to diversify sources.

5. How do regulatory standards impact API sourcing?

Suppliers must meet regional and international standards, such as GMP, to ensure market approval and supply continuity.

---

References

1. U.S. Food and Drug Administration (FDA). (2023). Drug master files and API supplier list. https://www.fda.gov
2. European Medicines Agency (EMA). (2022). API manufacturing standards and databases. https://www.ema.europa.eu
3. World Health Organization (WHO). (2023). Global API supply chains. https://www.who.int
4. Global Data. (2023). API manufacturing capacity report. https://www.globaldata.com
5. IQVIA. (2022). Pharmaceutical manufacturing and supply chain analysis. https://www.iqvia.com